AbbVie: Morgan Stanley raises target price to $346 from $310
ABBV•Morgan Stanley raised its target price for AbbVie to $346 from $310.
Related News
Criteo partners with Notino on retail media across 27 European markets
CRTO•
Evercore ISI raises ExxonMobil target price to $200 from $185
XOM•
Hacksaw Gaming expands FanDuel partnership to Connecticut
FLUT•
American Electric Power Company raises target price to $132 from $120
AEP•
Infomina secures Broadcom software distribution rights across 13 Asia-Pacific markets
AVGO•